Severe Asthma Investigational Medication

Trial Objective

The purpose of this trial is to see if an investigational oral medication is safe and has beneficial effects in people who have severe asthma that is poorly controlled, despite consistent use of inhaled steroids (such as Qvar, Pulmicort and Symbicort) plus a maintenance medication (such as Advair and Xolair).

Severe Asthma Investigational Medication

Enrollment

This trial is active and currently recruiting.

How to Participate

For more information, call 303.398.1233 or complete the form below.

Who Can Participate

Adults with poorly controlled asthma who consistently use inhaled steroids (such as Qvar, Pulmicort and Symbicort) plus a maintenance medication (such as Advair and Xolair).


Estimated Time Commitment

11 visits over 60 weeks

Trial Location

National Jewish Main Campus, Denver, CO

Compensation

Provided

Trial Sponsors

Novartis Pharmaceuticals Corporation

Age

18+


Gender

Any Gender

Principal Investigators


Request More Information

*
*
*
*